Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial

Transfusion

Volumn 58, Issue 4, 2018, Pages 974-981

  Gybel Brask, Mikkel ^a   Seeberg, Jens ^a   Thomsen, Lars L ^b,c   Johansson, Pär I ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c Pharmacosmos AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; IRON ISOMALTOSE; PLACEBO; TRANSFERRIN; ANTIANEMIC AGENT; DISACCHARIDE; FERRIC ION; IRON ISOMALTOSIDE 1000;

ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTITIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; EXERCISE TOLERANCE; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; FLU LIKE SYNDROME; HEADACHE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INJECTION SITE IRRITATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON STORAGE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAIN; PATIENT-REPORTED OUTCOME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; RETICULOCYTE COUNT; RHINOPHARYNGITIS; SINGLE DRUG DOSE; TRANSFERRIN SATURATION; URTICARIA; VOMITING; ADOLESCENT; BLOOD; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; MENSTRUATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD DONORS; DISACCHARIDES; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; FERRIC COMPOUNDS; FERRITINS; HEMATINICS; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MENSTRUATION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85041515292     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14521     Document Type: Article

References (21)

1. Rigas AS, Sorensen CJ, Pedersen OB, et al. Predictors of iron levels in 14,737 Danish blood donors: results from the Danish Blood Donor Study. Transfusion 2014;54:789-96.
2. Milman N. Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 1996;63:103-35.
3. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Brussels: European Commission; 2004 Mar 22. [cited 2018 Jan 26]. Available from: http://data.europa.eu/eli/dir/2004/33/oj
4. Bianco C, Brittenham G, Gilcher RO, et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002;42:798-805.
5. Goldberg ND. Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol 2013;6:61-70.
6. KDIGO clinical practice guideline for anemia in chronic kidney disease [Internet]. Vol. 2, Issue 4. KDIGO; 2012. [cited 2017 Oct 6]. Available from: http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO-Anemia%20GL.pdf.
7. Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 2015;9:211-22.
8. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13:1545-53.
9. Hildebrandt PR, Bruun NE, Nielsen OW, et al. Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study. TATM 2010;11:131-7.
10. Bhandari S, Kalra PA, Kothari J, et al. A randomized, open-label trial of iron isomaltoside 1000 (Monofer) compared with iron sucrose (Venofer) as maintenance therapy in haemodialysis patients. Nephrol Dial Transplant 2015;30:1577-89.
11. Kalra PA, Bhandari S, Saxena S, et al. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrol Dial Transplant 2016;31:646-55.
12. Birgegard G, Henry D, Glaspy J, et al. A randomized, noninferiority trial of intravenous iron isomaltoside versus oral iron sulfate in patients with nonmyeloid malignancies and anemia receiving chemotherapy, the PROFOUND trial. Pharmacotherapy 2016;36:402-14.
13. Dahlerup JF, Jacobsen BA, van der Woude J, et al. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23. Scand J Gastroenterol 2016;51:1332-8.
14. Derman R, Roman E, Modiano MR, et al. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. Am J Hematol 2017;92:286-91.
15. Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang 2015;109:257-66.
16. Holm C, Thomsen LL, Norgaard A, et al. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial. Vox Sang 2017;112:219-28.
17. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011;51:511-22.
18. Falkingham M, Abdelhamid A, Curtis P, et al. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J 2010;9:4
19. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007;85:778-87.
20. Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 2006;46:1667-81.
21. Kiss JE, Brambilla D, Glynn SA, et al. Oral iron supplementation after blood donation: a randomized clinical trial. JAMA 2015;313:575-83.